
Arena Pharmaceuticals ARNA
Annual report 2021
added 12-16-2023
Arena Pharmaceuticals Total Inventories 2011-2026 | ARNA
Annual Total Inventories Arena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 6.71 M | 9.5 M | 10.8 M | 12.8 M | 6.06 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.8 M | 6.06 M | 9.17 M |
Quarterly Total Inventories Arena Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.85 M | 7.06 M | 7.06 M | 6.71 M | 10.2 M | 6.71 M | 6.71 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 6.06 M | 6.06 M | 6.06 M | 6.06 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.8 M | 6.06 M | 9.04 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
143 M | $ 20.15 | -2.68 % | $ 2.54 B | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.82 | -3.48 % | $ 4.47 M | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 163.7 | -1.61 % | $ 8.14 B | ||
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.72 | -2.75 % | $ 1.11 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Codexis
CDXS
|
1.8 M | $ 0.99 | -3.28 % | $ 72.7 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
37.2 M | $ 24.0 | 0.5 % | $ 2.93 B | ||
|
Agenus
AGEN
|
55.5 K | $ 3.19 | -4.64 % | $ 1.14 M | ||
|
Agios Pharmaceuticals
AGIO
|
32.9 M | $ 28.78 | -1.44 % | $ 1.67 B | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Amarin Corporation plc
AMRN
|
196 M | $ 14.27 | 2.44 % | $ 5.92 B |